Press Releases

NIH-funded study in mice offers possible new target for high blood pressure treatments.

A biomarker of norepinephrine deficiency in the heart may help to detect Lewy body diseases before symptoms appear.

A research team supported by the National Institutes of Health has identified a part of the brain that may be associated with breathing failure following a seizure in people with severe epilepsy that cannot be controlled with medication.

Researchers have identified uric acid as a potential therapy to enhance recovery from acute ischemic stroke using a new method for conducting preclinical animal research.

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from treatment-resistant depression.

Study examined athletes who played contact sports, showed CTE symptoms, and died before age 30.

The results of an early-stage clinical trial indicate that deep brain stimulation (DBS) applied to the cerebellum may help recovery of upper limb function following stroke.

NIH-supported trial first step in developing new approach to treat myasthenia gravis

NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment.

For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders caused by stroke or amputation (phantom limb pain).